Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells.
Alpha-mangostin, an active compound in Garcinia mangostana, abrogates anoikis-resistance in human hepatocellular carcinoma cells.
Toxicol In Vitro. 2018 Sep 05;:
Authors: Wudtiwai B, Pitchakarn P, Banjerdpongchai R
Abstract
Anoikis-resistance is a critical step in cancer progression, especially during the process of metastasis. During this phase, the cancer phenotype that causes cell survival in detachment conditions, drug resistance, and epithelial-to-mesenchymal transition (EMT) is altered. Inhibition of anoikis-resistance can potentially be the molecular target in cancer therapy. Alpha-mangostin, an active compound in Garcinia mangostana, has been reported for its cell-death induction and its chemosensitizing and anti-metastatic properties in many cancer cell types, such as ovarian cancer, lung cancer, and hepatocellular carcinoma. We, therefore, have investigated whether alpha-mangostin could sensitize anoikis in human hepatocellular carcinoma (HepG2). The established anoikis-resistant HepG2 displayed more aggressive malignant behaviors, including rapid proliferation, doxorubicin resistance, up-regulated anti-apoptotic protein levels, and EMT phenotype. Alpha-mangostin significantly sensitized anoikis in HepG2 through the inhibition of cell survival by induced caspase-9, caspase-8 and caspase-3 activities, increased pro-apoptotic protein (Bax, Bim, t-Bid) levels, and decreased anti-apoptotic protein (c-FLIP, Mcl-1) levels. Beside...
Source: Toxicology in Vitro - Category: Toxicology Authors: Wudtiwai B, Pitchakarn P, Banjerdpongchai R Tags: Toxicol In Vitro Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Epithelial Cancer | Hepatocellular Carcinoma | Liver | Liver Cancer | Lung Cancer | Ovarian Cancer | Ovaries | Science | Toxicology | Urology & Nephrology